NEUROPLASTOGEN Trademark

Trademark Overview


On Tuesday, April 9, 2019, a trademark application was filed for NEUROPLASTOGEN with the United States Patent and Trademark Office. The USPTO has given the NEUROPLASTOGEN trademark a serial number of 88378640. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, June 5, 2020. This trademark is owned by PLMRD LLC. The NEUROPLASTOGEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical p...
neuroplastogen

General Information


Serial Number88378640
Word MarkNEUROPLASTOGEN
Filing DateTuesday, April 9, 2019
Status601 - ABANDONED - EXPRESS
Status DateFriday, June 5, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical products and preparations for chloasma; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Ferments for pharmaceutical purposes; Flaxseed for pharmaceutical purposes; Ocular pharmaceuticals; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Turpentine for pharmaceutical purposes, with all of the foregoing in compliance with the Controlled Substances Act and the Food Drug and Cosmetic Act

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePLMRD LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10004

Trademark Events


Event DateEvent Description
Friday, June 5, 2020ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Friday, June 5, 2020ABANDONMENT - EXPRESS MAILED
Thursday, June 4, 2020TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, June 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 2, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 23, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, December 23, 2019FINAL REFUSAL E-MAILED
Monday, December 23, 2019FINAL REFUSAL WRITTEN
Wednesday, December 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 24, 2019NON-FINAL ACTION E-MAILED
Tuesday, September 24, 2019NON-FINAL ACTION WRITTEN
Monday, September 16, 2019ASSIGNED TO EXAMINER
Thursday, August 29, 2019ASSIGNED TO EXAMINER
Wednesday, August 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 21, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 15, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 15, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 22, 2019NON-FINAL ACTION E-MAILED
Saturday, June 22, 2019NON-FINAL ACTION WRITTEN
Tuesday, June 18, 2019ASSIGNED TO EXAMINER
Friday, April 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 12, 2019NEW APPLICATION ENTERED IN TRAM